[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100590443":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":19,"locations":25,"responsibleParty":187,"collaborators":10,"id":189,"slug":10,"hasResults":190,"nctId":191,"briefTitle":192,"officialTitle":193,"acronym":10,"eligibilityCriteria":194,"healthyVolunteers":190,"sex":195,"minAge":196,"maxAge":10,"enrollmentInfo":197,"targetDuration":10,"studyType":200,"phases":10,"briefSummary":201,"conditions":202,"keywords":205,"overallStatus":28,"whyStopped":10,"lastUpdateSubmitDate":208,"lastUpdatePostDateStruct":209,"startDateStruct":212,"completionDateStruct":214,"leadSponsor":216,"locationsCount":217},{"fullName":5,"class":6},"Alexion Pharmaceuticals, Inc.","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Ravulizumab",null,"Participants will receive Ravulizumab until Week 50 ± 14 days after baseline or until discontinuation.",[13],"Drug: Ravulizumab",[15],{"type":16,"name":9,"description":17,"armGroupLabels":18,"otherNames":10},"DRUG","Participants will receive Ravulizumab.",[9],[20],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},"Alexion Pharmaceuticals, Inc. (Sponsor)","CONTACT","1-855-752-2356","clinicaltrials@alexion.com",[26,37,45,49,56,63,70,77,84,91,95,102,109,116,123,130,137,144,151,158,165,173,180],{"facility":27,"status":28,"city":29,"state":10,"zip":10,"country":30,"cosmosGeoPoint":31,"geoPoint":36,"contacts":10},"Clinical Trial Site","RECRUITING","Bergamo","Italy",{"type":32,"coordinates":33},"Point",[34,35],9.66721,45.69601,{"lat":35,"lon":34},{"facility":27,"status":38,"city":39,"state":10,"zip":10,"country":30,"cosmosGeoPoint":40,"geoPoint":44,"contacts":10},"NOT_YET_RECRUITING","Bologna",{"type":32,"coordinates":41},[42,43],11.33875,44.49381,{"lat":43,"lon":42},{"facility":27,"status":28,"city":39,"state":10,"zip":10,"country":30,"cosmosGeoPoint":46,"geoPoint":48,"contacts":10},{"type":32,"coordinates":47},[42,43],{"lat":43,"lon":42},{"facility":27,"status":28,"city":50,"state":10,"zip":10,"country":30,"cosmosGeoPoint":51,"geoPoint":55,"contacts":10},"Brescia",{"type":32,"coordinates":52},[53,54],10.21472,45.53558,{"lat":54,"lon":53},{"facility":27,"status":28,"city":57,"state":10,"zip":10,"country":30,"cosmosGeoPoint":58,"geoPoint":62,"contacts":10},"Florence",{"type":32,"coordinates":59},[60,61],11.24626,43.77925,{"lat":61,"lon":60},{"facility":27,"status":38,"city":64,"state":10,"zip":10,"country":30,"cosmosGeoPoint":65,"geoPoint":69,"contacts":10},"Imperia",{"type":32,"coordinates":66},[67,68],8.03933,43.88917,{"lat":68,"lon":67},{"facility":27,"status":28,"city":71,"state":10,"zip":10,"country":30,"cosmosGeoPoint":72,"geoPoint":76,"contacts":10},"Lecco",{"type":32,"coordinates":73},[74,75],9.39704,45.85589,{"lat":75,"lon":74},{"facility":27,"status":38,"city":78,"state":10,"zip":10,"country":30,"cosmosGeoPoint":79,"geoPoint":83,"contacts":10},"Messina",{"type":32,"coordinates":80},[81,82],15.55256,38.19394,{"lat":82,"lon":81},{"facility":27,"status":28,"city":85,"state":10,"zip":10,"country":30,"cosmosGeoPoint":86,"geoPoint":90,"contacts":10},"Milan",{"type":32,"coordinates":87},[88,89],12.59836,42.78235,{"lat":89,"lon":88},{"facility":27,"status":38,"city":85,"state":10,"zip":10,"country":30,"cosmosGeoPoint":92,"geoPoint":94,"contacts":10},{"type":32,"coordinates":93},[88,89],{"lat":89,"lon":88},{"facility":27,"status":38,"city":96,"state":10,"zip":10,"country":30,"cosmosGeoPoint":97,"geoPoint":101,"contacts":10},"Naples",{"type":32,"coordinates":98},[99,100],14.26811,40.85216,{"lat":100,"lon":99},{"facility":27,"status":38,"city":103,"state":10,"zip":10,"country":30,"cosmosGeoPoint":104,"geoPoint":108,"contacts":10},"Novara",{"type":32,"coordinates":105},[106,107],8.62118,45.44694,{"lat":107,"lon":106},{"facility":27,"status":38,"city":110,"state":10,"zip":10,"country":30,"cosmosGeoPoint":111,"geoPoint":115,"contacts":10},"Orbassano",{"type":32,"coordinates":112},[113,114],7.53813,45.00547,{"lat":114,"lon":113},{"facility":27,"status":38,"city":117,"state":10,"zip":10,"country":30,"cosmosGeoPoint":118,"geoPoint":122,"contacts":10},"Padova",{"type":32,"coordinates":119},[120,121],11.14261,44.38225,{"lat":121,"lon":120},{"facility":27,"status":38,"city":124,"state":10,"zip":10,"country":30,"cosmosGeoPoint":125,"geoPoint":129,"contacts":10},"Palermo",{"type":32,"coordinates":126},[127,128],13.3636,38.1166,{"lat":128,"lon":127},{"facility":27,"status":28,"city":131,"state":10,"zip":10,"country":30,"cosmosGeoPoint":132,"geoPoint":136,"contacts":10},"Parma",{"type":32,"coordinates":133},[134,135],10.32618,44.79935,{"lat":135,"lon":134},{"facility":27,"status":38,"city":138,"state":10,"zip":10,"country":30,"cosmosGeoPoint":139,"geoPoint":143,"contacts":10},"Pavia",{"type":32,"coordinates":140},[141,142],9.15917,45.19205,{"lat":142,"lon":141},{"facility":27,"status":38,"city":145,"state":10,"zip":10,"country":30,"cosmosGeoPoint":146,"geoPoint":150,"contacts":10},"Pisa",{"type":32,"coordinates":147},[148,149],10.4036,43.70853,{"lat":149,"lon":148},{"facility":27,"status":38,"city":152,"state":10,"zip":10,"country":30,"cosmosGeoPoint":153,"geoPoint":157,"contacts":10},"Roma",{"type":32,"coordinates":154},[155,156],11.10642,44.99364,{"lat":156,"lon":155},{"facility":27,"status":38,"city":159,"state":10,"zip":10,"country":30,"cosmosGeoPoint":160,"geoPoint":164,"contacts":10},"Salerno",{"type":32,"coordinates":161},[162,163],14.79328,40.67545,{"lat":163,"lon":162},{"facility":27,"status":28,"city":166,"state":10,"zip":167,"country":30,"cosmosGeoPoint":168,"geoPoint":172,"contacts":10},"San Giovanni Rotondo","71013",{"type":32,"coordinates":169},[170,171],15.7277,41.70643,{"lat":171,"lon":170},{"facility":27,"status":28,"city":174,"state":10,"zip":10,"country":30,"cosmosGeoPoint":175,"geoPoint":179,"contacts":10},"Sassari",{"type":32,"coordinates":176},[177,178],8.55552,40.72586,{"lat":178,"lon":177},{"facility":27,"status":38,"city":181,"state":10,"zip":10,"country":30,"cosmosGeoPoint":182,"geoPoint":186,"contacts":10},"Torino",{"type":32,"coordinates":183},[184,185],11.99138,44.88856,{"lat":185,"lon":184},{"type":188,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100590443",false,"NCT06967480","Early Ravulizumab Treatment Of Anti- AChR Antibody-Positive Generalized Myasthenia Gravis","MG-EVOLUTION. Early Ravulizumab Treatment Of Anti- AChR Antibody-Positive Generalized Myasthenia Gravis: A Real-World Study With Biomarker Analysis","Inclusion Criteria:\n\n* Diagnosis of MG confirmed by:\n\n  * History of a positive serologic test for anti-AChR antibodies, and\n  * One of the following:\n\n    * History of abnormal neuromuscular transmission test demonstrated by singlefibre electromyography or repetitive nerve stimulation\n    * History of positive anticholinesterase test (e.g., edrophonium chloride test); or\n    * Patient demonstrated improvement in MG signs on oral cholinesterase inhibitors, as assessed by the treating physician\n* Disease duration from MG onset ≤ 3 years before T-4 (Enrolment);\n* MGFA class IIb to IV;\n* Patient eligible for Ravulizumab treatment based on AIFA reimbursement criteria\n* Vaccination cycle for Neisseria meningitidis completed at least two weeks before Ravulizumab initiation or antibiotics chemoprophylaxis according to the SmPC.\n\nExclusion Criteria:\n\n* Patient unable to understand and sign the informed consent\n* Hypersensitivity to the active substance or to any of the excipients of the study product\n* Patient for whom the study product is contraindicated according to SmPC\n* Previous treatment with C5 inhibitors\n* Last rituximab infusion performed \\\u003C 6 months before T-4 (Enrolment)\n* Last infusion with FcRn blockers performed \\\u003C 3 months before T-4 (Enrollment)\n* Pregnant or lactating or planning a pregnancy during the study\n* Patient who plan to relocate during the study\n* Patient who are unsure of following the visit schedule\n* Patient unable to complete questionnaires\n* Previous or current participation to other interventional studies","ALL","18 Years",{"count":198,"type":199},40,"ESTIMATED","OBSERVATIONAL","The primary objective of the study is to evaluate the effectiveness of Ravulizumab in improving MG-ADL in an early-stage AChR+ gMG population.",[203,204],"Generalized Myasthenia Gravis","Anti-AChR Antibody Positive",[206,203,207,9],"Anti-AChR Antibody-Positive","gMG","2026-02-04",{"date":210,"type":211},"2026-02-05","ACTUAL",{"date":213,"type":211},"2025-07-31",{"date":215,"type":199},"2027-06-30",{"name":5,"class":6},23]